Page last updated: 2024-08-25

dexrazoxane and Liver Neoplasms

dexrazoxane has been researched along with Liver Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bize, P; Denys, A; Deplanque, G; Duran, R; Orcurto, A; Shabafrouz, K; Stalder, G	1

Other Studies

1 other study(ies) available for dexrazoxane and Liver Neoplasms

Article	Year
Dexrazoxane prevents skin necrosis in non-target embolization of falciform artery during transcatheter arterial chemoembolization (TACE). Diagnostic and interventional imaging, 2018, Volume: 99, Issue:3 Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Dermatologic Agents; Dexrazoxane; Drug Eruptions; Embolization, Therapeutic; Hepatic Artery; Humans; Liver Neoplasms; Male; Necrosis; Skin	2018

Article

Year

Dexrazoxane prevents skin necrosis in non-target embolization of falciform artery during transcatheter arterial chemoembolization (TACE).

Diagnostic and interventional imaging, 2018, Volume: 99, Issue:3

Topics: Aged; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Dermatologic Agents; Dexrazoxane; Drug Eruptions; Embolization, Therapeutic; Hepatic Artery; Humans; Liver Neoplasms; Male; Necrosis; Skin

2018